Sino Biopharmaceutical(DE:SMZ1)
€0.65+0.04 (+5.65%)
DE:SMZ1
Sino Biopharmaceutical financials statements
€0.65
At close:+0.04 (+5.65%)
Sino Biopharmaceutical (SMZ1) Income Statement
0 Followers
Sino Biopharmaceutical Income Statement
Last quarter (Q2 2026), Sino Biopharmaceutical's total revenue was ¥9.72B, an increase of 10.64% from the same quarter last year. In Q2, Sino Biopharmaceutical's net income was ¥1.72B. See Sino Biopharmaceutical’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 31.83B | ¥ 28.87B | ¥ 26.20B | ¥ 26.03B | ¥ 26.86B | |
| ¥ 26.13B | ¥ 23.53B | ¥ 21.21B | ¥ 21.54B | ¥ 21.53B | |
| ¥ 19.17B | ¥ 17.39B | ¥ 15.54B | ¥ 15.95B | ¥ 16.45B | |
| Depreciation and Amortization | ¥ 1.21B | ¥ 1.32B | ¥ 1.07B | ¥ 1.05B | ¥ 992.56M |
| ¥ 7.50B | ¥ 6.49B | ¥ 6.98B | ¥ 6.69B | ¥ 19.87B | |
| ¥ 6.95B | ¥ 6.14B | ¥ 5.67B | ¥ 5.59B | ¥ 5.16B | |
| ¥ -10.21M | ¥ -858.09M | ¥ -259.97M | ¥ -370.95M | ¥ 13.49B | |
| ¥ 6.94B | ¥ 5.28B | ¥ 5.41B | ¥ 5.21B | ¥ 18.57B | |
| ¥ 2.34B | ¥ 3.50B | ¥ 2.33B | ¥ 2.54B | ¥ 14.61B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.13 | ¥ 0.10 | ¥ 0.10 | ¥ 0.11 | ¥ 0.78 |
| Diluted EPS | ¥ 0.13 | ¥ 0.10 | ¥ 0.10 | ¥ 0.12 | ¥ 0.73 |
| Weighted Average Shares Outstanding | 18.05B | 17.24B | 18.53B | 18.62B | 18.77B |
| Weighted Average Shares Outstanding (Diluted) | 18.06B | 18.30B | 18.53B | 19.02B | 19.28B |
Currency in CNY
